M-43 Global vaccine equity

That, in the opinion of the House, the government should do more to address global vaccine equity by sharing resources, doses, and knowledge, including action to:

(a) donate at least 200 million doses, as promised, to vulnerable populations around the world through COVAX by the end of 2022, and ensure that all excess doses pursuant to Canada’s contracts are transferred as soon as possible;

(b) deliver an additional $1.1 billion as a net addition to the International Assistance Envelope and existing departmental resources to address global vaccine equity in Budget 2022, including:

(i) $780 million to Act-Accelerator partners to purchase vaccines, tests, treatments, PPR and oxygen in developing countries,

(ii) $290 million to strengthen pandemic preparedness and response capacity, including support for in-country delivery costs;

(c) contribute to a significant increase in global manufacturing capabilities for vaccines and other tools to fight COVID-19, including by:

(i) supporting the temporary waiver of intellectual property rights related to prevention, containment or treatment of COVID-19 at the World Trade Organization,

(ii) facilitating the transfer of technology to manufacture COVID-19 vaccines around the world, including financial support for regional hubs such as the South Africa Technology Transfer Hub; and

(d) report to Parliament on the progress of these actions by no later than Monday, June 20, 2022.